HERON THERAPEUTICS, INC. /DE/ Annual Share-based Payment Arrangement, Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2023.
  • Heron Therapeutics, Inc. /De/ Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $4.57M, a 67.1% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $19M, a 56.5% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2023 was $32.9M, a 23.6% decline from 2022.
  • Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2022 was $43M, a 8.26% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2021 was $46.9M, a 6.71% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $32.9M -$10.1M -23.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $43M -$3.87M -8.26% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $46.9M -$3.37M -6.71% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $50.2M -$1.19M -2.32% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $51.4M +$18M +54.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $33.4M +$2.83M +9.26% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $30.5M +$4.58M +17.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $26M +$11.6M +80.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-22
2015 $14.4M +$6.29M +78% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $8.07M -$2.82M -25.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 $10.9M +$5.16M +90% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $5.73M +$3.84M +203% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 $1.89M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.